![](/img/cover-not-exists.png)
454PDFirst in human, a phase I study of ISU104, a novel ErbB3 monoclonal antibody, in patients with advanced solid tumours
Kim, S -B, Keam, B, Shin, S, Chae, Y S, Kim, T M, Kim, M -S, Kim, J G, Park, K, Ahn, J S, Park, L C, Lee, E, Juhn, J, Kim, S, Hong, S -B, Ahn, M -JVolume:
30
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdz244.016
Date:
October, 2019
File:
PDF, 91 KB
2019